Singapore
FathomX, founded in 2019 and headquartered in Singapore, is a prominent player in the intersection of AI, Medical Devices, and Machine Learning, with a focus on Education. Their mission, encapsulated in their slogan, "Technologies for women's health," reflects their commitment to revolutionizing public health.
As a MedTech AI spin-off from the National University of Singapore and National University Health System, FathomX aims to enhance clinical workflows. Their flagship project endeavors to reduce breast cancer screening false positives by 80%, while streamlining the need for clinicians by 50%. These innovations are backed by research published in JAMA Open Network and the AAAI Workshop.
The company collaborates with HP Enterprise to integrate its scalable AI solutions into medical imaging, with successful trials across hospitals and clinics. The latest strategic boost came in the form of a grant investment on 06 June 2023, underscoring the potential and growing interest in FathomX's initiatives.
